Business Description
TRACON Pharmaceuticals Inc
NAICS : 325411
SIC : 2836
ISIN : US89237H1005
Description
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 36.29 | |||||
| Equity-to-Asset | -0.08 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -30.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 72.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.89 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -41.9 | |||||
| Shareholder Yield % | -35.36 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -73.87 | |||||
| Net Margin % | -29.79 | |||||
| FCF Margin % | -4.39 | |||||
| ROA % | -30.15 | |||||
| ROIC % | -204.19 | |||||
| ROC (Joel Greenblatt) % | 826.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.26 | |||||
| EV-to-EBIT | -1.06 | |||||
| EV-to-EBITDA | -1.05 | |||||
| EV-to-Revenue | -0.33 | |||||
| EV-to-FCF | -1.07 | |||||
| Earnings Yield (Greenblatt) % | -94.34 | |||||
| FCF Yield % | 83.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TRACON Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.307 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 3.58 - 3.58 | ||
| Shares Outstanding (Mil) | 19.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TRACON Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TRACON Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
TRACON Pharmaceuticals Inc Frequently Asked Questions
What is TRACON Pharmaceuticals Inc(STU:T051)'s stock price today?
The current price of STU:T051 is €3.58. The 52 week high of STU:T051 is €3.58 and 52 week low is €3.58.
When is next earnings date of TRACON Pharmaceuticals Inc(STU:T051)?
The next earnings date of TRACON Pharmaceuticals Inc(STU:T051) is 2024-05-14.
Does TRACON Pharmaceuticals Inc(STU:T051) pay dividends? If so, how much?
TRACON Pharmaceuticals Inc(STU:T051) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers